# OnCo record aphinity (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aphinity/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aphinity", "NCT01358877" ;
  schema:name "APHINITY"@en ;
  schema:description "Adding pertuzumab after surgery helps women whose cancer had reached the lymph nodes, by a few percentage points, and does not help those with node-negative disease."@en ;
  schema:url <https://onco.cc/trials/aphinity/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01358877> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2011-11-08" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/her2-positive-early-breast-cancer/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:companies <https://onco.cc/companies/breast-cancer-trials/> ;
  onco:people <https://onco.cc/people/david-cameron/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-aphinity-nejm-2017/>, <https://onco.cc/key-papers/paper-aphinity-j-clin-oncol-2024-update/> .